Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights

被引:109
作者
Cherry, M [1 ]
Williams, DH [1 ]
机构
[1] Millennium Pharmaceut Res & Dev Ltd, Struct Based Discovery, Cambridge CB1 6ET, England
关键词
X-ray crystal structure; protein kinase; ATP-binding site; inhibitor; regulation; selectivity;
D O I
10.2174/0929867043455792
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent years have seen an explosion in the number of publicly available x-ray crystal structures of protein kinases. These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes. Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, molecular templates for ATP competitive inhibitors and alternative mechanisms of inhibition. The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity. In addition, protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition. The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.
引用
收藏
页码:663 / 673
页数:11
相关论文
共 50 条
[1]   A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis [J].
Adams, J ;
Huang, P ;
Patrick, D .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :486-492
[2]   Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles [J].
Arris, CE ;
Boyle, FT ;
Calvert, AH ;
Curtin, NJ ;
Endicott, JA ;
Garman, EF ;
Gibson, AE ;
Golding, BT ;
Grant, S ;
Griffin, RJ ;
Jewsbury, P ;
Johnson, LN ;
Lawrie, AM ;
Newell, DR ;
Noble, MEM ;
Sausville, EA ;
Schultz, R ;
Yu, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (15) :2797-2804
[3]   The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2 [J].
Battistutta, R ;
Sarno, S ;
De Moliner, E ;
Papinutto, E ;
Zanotti, G ;
Pinna, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29618-29622
[4]   Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis [J].
Bramson, HN ;
Corona, J ;
Davis, ST ;
Dickerson, SH ;
Edelstein, M ;
Frye, SV ;
Gampe, RT ;
Harris, PA ;
Hassell, A ;
Holmes, WD ;
Hunter, RN ;
Lackey, KE ;
Lovejoy, B ;
Luzzio, MJ ;
Montana, V ;
Rocque, WJ ;
Rusnak, D ;
Shewchuk, L ;
Veal, JM ;
Walker, DH ;
Kuyper, LF .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4339-4358
[5]   BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice [J].
Burke, JR ;
Pattoli, MA ;
Gregor, KR ;
Brassil, PJ ;
MacMaster, JF ;
McIntyre, KW ;
Yang, XX ;
Iotzova, VS ;
Clarke, W ;
Strnad, J ;
Qiu, YP ;
Zusi, FC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1450-1456
[6]   Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor [J].
Davies, TG ;
Bentley, J ;
Arris, CE ;
Boyle, FT ;
Curtin, NJ ;
Endicott, JA ;
Gibson, AE ;
Golding, BT ;
Griffin, RJ ;
Hardcastle, IR ;
Jewsbury, P ;
Johnson, LN ;
Mesguiche, V ;
Newell, DR ;
Noble, MEM ;
Tucker, JA ;
Wang, L ;
Whitfield, HJ .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (10) :745-749
[7]   RETRACTED: Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors (Retracted Article. See vol 298, pg 2327, 2002) [J].
Davis, ST ;
Benson, BG ;
Bramson, HN ;
Chapman, DE ;
Dickerson, SH ;
Dold, KM ;
Eberwein, DJ ;
Edelstein, M ;
Frye, SV ;
Gampe, RT ;
Griffin, RJ ;
Harris, PA ;
Hassell, AM ;
Holmes, WD ;
Hunter, RN ;
Knick, VB ;
Lackey, K ;
Lovejoy, B ;
Luzzio, MJ ;
Murray, D ;
Parker, P ;
Rocque, WJ ;
Shewchuk, L ;
Veal, JM ;
Walker, DH ;
Kuyper, LF .
SCIENCE, 2001, 291 (5501) :134-137
[8]   THE OCCURRENCE OF C-H-CENTER-DOT-CENTER-DOT-CENTER-DOT-O HYDROGEN-BONDS IN PROTEINS [J].
DEREWENDA, ZS ;
LEE, L ;
DEREWENDA, U .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 252 (02) :248-262
[9]   Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717 [J].
Dreyer, MK ;
Borcherding, DR ;
Dumont, JA ;
Peet, NP ;
Tsay, JT ;
Wright, PS ;
Bitonti, AJ ;
Shen, J ;
Kim, SH .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (04) :524-530
[10]   Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89 - Structural implications for selectivity [J].
Engh, RA ;
Girod, A ;
Kinzel, V ;
Huber, R ;
Bossemeyer, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :26157-26164